Acinetobacter baumannii is emerging as an important nosocomial pathogen worldwide. We
report molecular epidemiology of 65 carbapenem-nonsusceptible A. baumannii isolates …

Despite the increasing prevalence of the nosocomial pathogen Acinetobacter baumannii,
little is known about which genomic components contribute to clinical presentation of this …

The epidemiology of Acinetobacter baumannii emerging in combat casualties is poorly
understood. We analyzed 65 (54 nonreplicate) Acinetobacter isolates from 48 patients (46 …

Background Acinetobacter baumannii is a notorious opportunistic pathogen mainly
associated with hospital-acquired infections. Studies on the clonal relatedness of isolates …

Background Nosocomial outbreaks of multidrug-resistant Acinetobacter baumannii are of
worldwide concern. Using pulsed-field gel electrophoresis (PFGE), multilocus sequence …

To investigate the species distribution within the Acinetobacter calcoaceticus–Acinetobacter
baumannii complex and the molecular epidemiology of A. baumannii and Acinetobacter …

Background Antibiotic resistant strains of Acinetobacter baumannii have been responsible
for an increasing number of nosocomial infections including bacteremia and ventilator …

Objectives Acinetobacter baumannii presents a clinical challenge when it is non-susceptible
to carbapenems. The prevalence of carbapenem-non-susceptible A. baumannii in Japan is …

Carbapenem antibiotics are among the mainstays for treating infections caused by
Acinetobacter baumannii, especially in the Northwest United States, where carbapenem …

One hundred and twenty-six epidemiologically sequential, unrelated, carbapenem-resistant
Acinetobacter baumannii isolates from nine hospitals in six countries of South America were …